I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A randomized, crossover, phase I clinical study to evaluate..:
Xu, Zhongnan
;
Wang, Yanli
;
Liu, Zhengzhi
...
International Immunopharmacology. 109 (2022) - p. 108780 , 2022
Link:
https://doi.org/10.1016/j.intimp.2022.108780
RT Journal T1
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.intimp.2022.108780&Exemplar=1&LAN=DE A1 Xu, Zhongnan A1 Wang, Yanli A1 Liu, Zhengzhi A1 Zhang, Renjie A1 Zhou, Yannan A1 Yu, Jing A1 Lan, Jing A1 Liang, Wenzhong A1 Liu, Guangwen A1 Qu, Xinyao A1 Chen, Jiahui A1 Su, Zhengjie A1 Yu, Shuang A1 Cheng, Yang A1 Wang, Wanhua A1 Ren, Qing A1 Deng, Qiaohuan A1 Zhao, Yicheng A1 Yang, Haimiao PB Elsevier BV YR 2022 SN 1567-5769 JF International Immunopharmacology VO 109 SP 108780 LK http://dx.doi.org/https://doi.org/10.1016/j.intimp.2022.108780 DO https://doi.org/10.1016/j.intimp.2022.108780 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)